コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 t attributable to right ventricular failure (chronic thromboembolic pulmonary hypertension).
2 ients (mean age, 57 years) underwent PEA for chronic thromboembolic pulmonary hypertension.
3 operated and not-operated patients who have chronic thromboembolic pulmonary hypertension.
4 studies to be beneficial in the treatment of chronic thromboembolic pulmonary hypertension.
5 t of pulmonary hemodynamics in patients with chronic thromboembolic pulmonary hypertension.
6 t of pulmonary hemodynamics in patients with chronic thromboembolic pulmonary hypertension.
7 lmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension.
8 complication of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
9 ubset that was not observed in patients with chronic thromboembolic pulmonary hypertension.
10 endarterectomy is a successful treatment of chronic thromboembolic pulmonary hypertension.
11 e treatment of choice for many patients with chronic thromboembolic pulmonary hypertension.
12 patients with severe compared with nonsevere chronic thromboembolic pulmonary hypertension.
13 pulmonary angioplasty to treat patients with chronic thromboembolic pulmonary hypertension.
14 l disease who successfully underwent PTE for chronic thromboembolic pulmonary hypertension.
16 ation of patients at higher risk of dying of chronic thromboembolic pulmonary hypertension and identi
17 ulmonary arterial hypertension or inoperable chronic thromboembolic pulmonary hypertension and impair
18 curring after venous thromboembolism include chronic thromboembolic pulmonary hypertension and post-t
19 tension are pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension, and pulmo
20 thin the pulmonary arteries of patients with chronic thromboembolic pulmonary hypertension are unknow
21 lmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension by high te
22 mapping of the LV in patients with RVF after chronic thromboembolic pulmonary hypertension (CTEPH) (R
28 DL-C levels was assessed in 34 patients with chronic thromboembolic pulmonary hypertension (CTEPH) un
30 rstanding of the pathophysiological basis of chronic thromboembolic pulmonary hypertension (CTEPH) wi
31 rectomy (PTE) is the preferred treatment for chronic thromboembolic pulmonary hypertension (CTEPH), b
32 y successful for the definitive treatment of chronic thromboembolic pulmonary hypertension (CTEPH), n
33 Doppler diastolic filling characteristics in chronic thromboembolic pulmonary hypertension (CTEPH).
34 lic filling characteristics in patients with chronic thromboembolic pulmonary hypertension (CTEPH).
35 thromboendarterectomy (PTE) in patients with chronic thromboembolic pulmonary hypertension (CTEPH).
36 lar resistance indicated severe or nonsevere chronic thromboembolic pulmonary hypertension (> 900 or
42 ndomly assigned 261 patients with inoperable chronic thromboembolic pulmonary hypertension or persist
43 AND We performed a retrospective analysis of chronic thromboembolic pulmonary hypertension patients r
45 For patients who are inoperable and have chronic thromboembolic pulmonary hypertension, riociguat
46 ent neovessels within vascular occlusions in chronic thromboembolic pulmonary hypertension suggests t
48 mbolism is epidemiologically associated with chronic thromboembolic pulmonary hypertension, the facto
50 findings in 55 patients suspected of having chronic thromboembolic pulmonary hypertension were analy
51 eview board-approved study, 20 patients with chronic thromboembolic pulmonary hypertension were exami
52 A total of 679 patients newly diagnosed with chronic thromboembolic pulmonary hypertension were prosp
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。